Practice Variation in Preoperative Multidisciplinary Team Discussions
NCT ID: NCT05305053
Last Updated: 2024-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
225 participants
OBSERVATIONAL
2022-04-01
2024-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Practice Variation in Preoperative MDT Meetings
NCT05797116
Effects of Preoperative Multidisciplinary Team Meetings for High-risk, Adult, Noncardiac Surgical Patients
NCT05703230
Anesthesia Geriatric Evaluation and Quality of Life After Cardiac Surgery
NCT02535728
Anesthesia Geriatric Evaluation and Quality of Life After Peripheral Vascular Surgery
NCT02820831
Do Anesthesiologists Follow Belgian KCE Guidelines for Preoperative Evaluation?
NCT05805124
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Several international guidelines have recommended MDT discussions for high-risk patients but they are not widely implemented yet. (7-9) Not executing preoperative MDT meetings may be a consequence of the fact that objective evidence for the value of the preoperative MDT meetings for high-risk, noncardiac patients is practically nonexistent. Also, no guidance exists on how best to organize an MDT meeting. Sroka proposes a protocol for the identification and multidisciplinary discussion of predefined high-risk patients.(2) In the current multicenter observational study in the Netherlands, the aim is to document how preoperative MDT meetings for high-risk non-cardiac surgery patients are executed. For the hospitals where MDT meetings are executed, considerable practice variation between hospitals may exist concerning performing and organizing MDT meetings. The practice variation may exist regarding patient selection, MDT meeting organization and attendance, MDT discussions, decisions made and, lastly, regarding nonsurgical management.
The first objective of this study is to describe the practice variation in executing preoperative MDT meetings in the presence of an anesthesiologist. The research question is: How much and what kind of variation exists in execution of preoperative MDT meetings for high-risk non-cardiac surgical patients. Secondary objectives are: what is the frequency of care management changes ordered by an MDT discussion; how do these changes affect outcome of the patients measured by the frequency of Serious adverse events; 30 day, 3 months and 12 months mortality postoperatively or post MDT discussion; calculated risks; differences in high-risk patient identification and the relation between calculated risks and outcome.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
high-risk noncardiac surgery patients for preoperative Multidisciplinary Team (MDT) discussion
observation of MDT in 11 hospitals
preoperative MDT discussion
high-risk patients are subjected to an MDT discussion among care providers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
preoperative MDT discussion
high-risk patients are subjected to an MDT discussion among care providers
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
16 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rijnstate Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jacqueline Vernooij
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jacqueline M Vernooij, MD
Role: PRINCIPAL_INVESTIGATOR
Rijnstate
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rijnstate Hospital
Arnhem, Gelderland, Netherlands
Gelderse Vallei
Ede, Gelderland, Netherlands
Catharina Ziekenhuis
Eindhoven, North Brabant, Netherlands
MC Leeuwarden
Leeuwarden, Provincie Friesland, Netherlands
Amsterdam University Medical Centre location VU
Amsterdam, South Holland, Netherlands
LUMC
Leiden, South Holland, Netherlands
Maasstad Ziekenhuis
Rotterdam, South Holland, Netherlands
Franciscus Gasthuis
Rotterdam, South Holland, Netherlands
UMCU
Utrecht, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-1952
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.